Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism-Reference-Cited by-同舟云学术

Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism

Author:

Arachchillage D. R. J.¹,Mackie I. J.¹,Efthymiou M.¹,Chitolie A.¹,Hunt B. J.²³,Isenberg D. A.⁴,Khamashta M.⁵⁶,Machin S. J.¹,Cohen H.¹⁷

Affiliation:

1. Department of Haematology; Haemostasis Research Unit; University College London; London UK

2. Thrombosis and Haemophilia; Guy's and St Thomas’ NHS Foundation Trust; London UK

3. Department of Haematology; Kings College London; London UK

4. Centre for Rheumatology, Division of Medicine; University College London; London UK

5. Lupus Research Unit; Guy's and St Thomas’ NHS Foundation Trust; London UK

6. Department of Rheumatology; Kings College London; London UK

7. Department of Haematology; University College London Hospitals NHS Foundation Trust; London UK

Funder

Arthritis Research UK

University College London

Bayer HealthCare

LUPUS UK

Publisher

Wiley

Subject

Hematology

Link

Reference54 articles.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献